Evidence map›Paper›PMID 42834283›Full record

ArticleJournal of general internal medicine2026

Videographic Analysis of an Intervention to Improve Patient-Centered Care for People Living with Type 2 Diabetes: The QBSAFE Randomized Trial.

Victor Montori V, Felipe Larios, Satya Sai Sri Bandi, Ana Cristina Proano, Kerly Guevara, Luis Vilatuna, Shubhangi Bagewadi, Anka van Gastel, Megan E Branda, Anne W Camp and 4 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05553912 (QBSafe), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05553912 nacompletednot on this map

QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.

TypeinterventionalSponsorYale UniversityRan2022 to 2025Enrolled154ConditionsType2Diabetes, DiabetesArmsQBSafe
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Victor Montori V *Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.
Felipe Larios *Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.
Satya Sai Sri BandiKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.
Ana Cristina ProanoKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.
Kerly GuevaraKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.
Luis VilatunaKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.
Shubhangi BagewadiKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.
Anka van GastelKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.
Megan E BrandaKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.
Anne W CampFair Haven Community Health Center, New Haven, CT, USA.
Mel MontosaFair Haven Community Health Center, New Haven, CT, USA.
Rozalina G McCoyUniversity of Maryland School of Medicine, Baltimore, MD, USA.
Victor M MontoriKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.
Kasia J LipskaYale School of Medicine, New Haven, CT, USA. kasia.lipska@yale.edu.ORCID http://orcid.org/0000-0002-0348-742X

Funding

QBSafe: a randomized trial of a novel intervention to improve care for people living with type 2 diabetes.R01DK129616 · NIDDK · YALE UNIVERSITY · PI LIPSKA, KASIA JOANNA · 2022 to 2024
$840k
NIDDK NIH HHS R01DK129616
6 · The paper itself

Abstract

backgroundClinical encounters between people living with type 2 diabetes and their primary care clinicians often emphasize metabolic control over self-management concerns.

objectiveTo determine whether QBSAFE cards were used as intended, their effect on the topics of discussion, and whether they enabled clinicians to notice and respond to patients' situations.

designAt a federally qualified primary care clinic, participants were randomly assigned to usual care with or without QBSAFE cards. Visits were video recorded.

participantsEleven clinicians and 155 of their patients with diabetes and HbA1c > 8%.

interventionFourteen QBSAFE cards addressing issues related to quality of life, burden of treatment, safety, and prevention of diabetes complications. MAIN MEASURES: Eight trained reviewers analyzed videos using a structured codebook to capture encounter characteristics, assess fidelity, and to record domain-specific discussions and degree of clinician responsiveness to issues raised by patients. KEY

resultsOf 143 eligible encounters (12 of 155 were found to have HbA1c  ≤ 8% post-randomization), 137 (65 usual care, 72 QBSAFE) yielded evaluable videos. QBSAFE cards were used as intended in 61 (85%) QBSAFE arm encounters. Compared to usual care, conversations about burden of treatment related to nonpharmacological interventions (17 vs 33, OR 2.38, 95% CI 1.11-5.12) and to taking medications (11 vs 33, OR 4.29, 95% CI 1.78-10.37) and about the patient's challenging environment (2 vs 10, OR 5.08, 95% CI 1.05-24.50) were more prevalent in the QBSAFE arm. There were no between-arm differences in metabolic control discussions or new care plans or in encounter duration. QBSAFE encounters were more likely to be considered unhurried.

conclusionsQBSAFE cards led to small patient-centered changes to encounter conversations, promoting ones about treatment burden, without displacing metabolic control discussions. Future work will focus on assisting clinicians in responding more effectively to patient issues so that raising these could change plans of care.

trial registrationClinicalTrials.gov NCT05553912, registered 9/21/2022.

Indexed as

conversation cardsdiabetes distressillness intrusivenessrandomized clinical trialType 2 diabetes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.